Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25421974 | 1.00 | EPHX2 (0.46) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL25422707 | 0.98 | EPHX2 (0.48) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL25227873 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL29185015 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL28948897 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL25236007 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL25271740 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL25231762 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL31106065 | 0.95 | EPHX2 (0.47) | EPHX2PPARAFAAHCNR1CNR2 | |
| SCHEMBL28923271 | 0.92 | LMNA (0.42) | EPHX2PPARAFAAHKCNH2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250049660-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2025-02-13 | — | — | US | disclosed |
| EP-4416125-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| CN-118369306-A | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2024-07-19 | — | — | CN | disclosed |
| WO-2023111006-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049660-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | EPHX2 118/4885PPARA 306/4885FAAH 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.